Finance

Lists
Outlook: 72.0% bullish·0.0% bearish
Go to analysis
MDT:NYSE
Medtronic PLC
85,51 US$
-1,81%
(-1,58) 1D
85,60 US$
+0,11% (+0,095)
After hours
Closed: 7 ოქტ, 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDT...
Open
87,40 US$
High
88,19 US$
Low
85,42 US$
Mkt. cap
109,38 მლრ.
Avg. vol.
14,96 მლნ.
Volume
162,00
Dividend
3,37%
Quarterly dividend
0,72 US$
Ex-dividend date
25 სექ. 2026
P/E ratio
21,05
52-wk high
106,33 US$
52-wk low
73,31 US$
EPS
4,06 US$
Beta
0,55
Shares outstanding
1,28 მლრდ.
No. of employees
95 ათ.
Open
87,40 US$
High
88,19 US$
Low
85,42 US$
Mkt. cap
109,38 მლრ.
Avg. vol.
14,96 მლნ.
Volume
162,00
Dividend
3,37%
Quarterly dividend
0,72 US$
Ex-dividend date
25 სექ. 2026
P/E ratio
21,05
52-wk high
106,33 US$
52-wk low
73,31 US$
EPS
4,06 US$
Beta
0,55
Shares outstanding
1,28 მლრდ.
No. of employees
95 ათ.
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
49 წუთის წინ
Barclays starts coverage of Medtronic stock at Equal Weight
Investing.com
Investing.com
·
12 საათის წინ
Medtronic sets final exchange ratio for MiniMed split-off
Stock Titan
Stock Titan
·
13 საათის წინ
[425] Medtronic plc Business Combination Communication
Profile
Medtronic plc is an Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOჯეფრი ეს მართა
Employees95 ათ.
Founded1949
Headquarters-
SectorMedical device
Analyst ratings
Based on 20 analysts giving stock ratings to MDT in the past 3 months
Buy
Buy
11
Hold
9
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for MDT in the last 3 months.
Highest
Current 85,51 US$
118,00 US$ (+38,00%)
Average
102,82 US$ (+20,24%)
Lowest
85,00 US$ (-0,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Christopher Pasquale
Barclays
Hold
Initiated
95,00 US$
+11,1%
10/06/2026
Matt Miksic
Barclays
Hold
Initiated
95,00 US$
+11,1%
10/06/2026
Joanne Wuensch
Citi
Buy
Maintained
110,00 US$
+28,6%
10/05/2026
Kendall Au
RBC Capital
Buy
Maintained
118,00 US$
+38%
10/01/2026
Josh Jennings
TD Cowen
Buy
Reiterated
110,00 US$
+28,6%
09/30/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
85,00 US$
-0,6%
09/28/2026
Michael Matson
Needham
Buy
Maintained
114,00 US$
+33,3%
09/17/2026
Travis Steed
Bank of America Securities
Buy
Maintained
110,00 US$
+28,6%
09/14/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
104,00 US$
+21,6%
09/09/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
96,00 US$
+12,3%
09/03/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
92,00 US$
+7,6%
09/03/2026
Patrick Wood
UBS
Buy
Reiterated
110,00 US$
+28,6%
09/03/2026
Anthony Petrone
Mizuho Securities
Buy
Reiterated
115,00 US$
+34,5%
09/02/2026
Jayson Bedford
Raymond James
Hold
Maintained
-
-
09/02/2026
Matthew Taylor
Jefferies
Hold
Reiterated
95,00 US$
+11,1%
09/02/2026
Richard Newitter
Truist Financial
Hold
Reiterated
99,00 US$
+15,8%
09/02/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
118,00 US$
+38%
09/01/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
95,00 US$
+11,1%
09/02/2026
David Rescott
Robert W. Baird
Hold
Maintained
100,00 US$
+16,9%
09/02/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
100,00 US$
+16,9%
09/01/2026
Priya Sachdeva
UBS
Buy
Upgraded
100,00 US$
+16,9%
07/28/2026
Mike Kratky
Leerink Partners
Buy
Maintained
-
-
07/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
105,00 US$
+22,8%
07/06/2026
David Roman
Goldman Sachs
Hold
Maintained
83,00 US$
-2,9%
06/04/2026
Lee Hambright
Bernstein
Buy
Maintained
97,00 US$
+13,4%
06/04/2026
David Toung
Argus Research
Buy
Maintained
115,00 US$
+34,5%
04/06/2026
Nico Chen
DBS
Hold
Maintained
90,00 US$
+5,3%
03/18/2026
Unknown Analyst
CICC
Buy
Initiated
121,00 US$
+41,5%
01/30/2026
Last report
1 სექ. 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
1,45 US$ / 1,39 US$
+4,51%beat
Revenue / Est. (USD)
9,76 მლრდ. / 9,54 მლრდ.
+2,21%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ოქტ. 2025
იან. 2026
აპრ. 2026
ივლ. 2026
Revenue
8,96 მლრდ.
9,02 მლრდ.
9,81 მლრდ.
9,76 მლრდ.
Cost of goods sold
3,06 მლრდ.
3,17 მლრდ.
3,40 მლრდ.
3,41 მლრდ.
Cost of revenue
3,06 მლრდ.
3,17 მლრდ.
3,40 მლრდ.
3,41 მლრდ.
Research and development expenses
754,00 მლნ.
722,00 მლნ.
671,00 მლნ.
771,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,94 მლრდ.
2,93 მლრდ.
3,04 მლრდ.
3,17 მლრდ.
Operating expense
4,08 მლრდ.
4,04 მლრდ.
4,25 მლრდ.
4,46 მლრდ.
Total operating expenses
7,14 მლრდ.
7,21 მლრდ.
7,64 მლრდ.
7,87 მლრდ.
Operating income
1,82 მლრდ.
1,80 მლრდ.
2,16 მლრდ.
1,89 მლრდ.
Other non operating income
3,00 მლნ.
13,00 მლნ.
154,00 მლნ.
33,00 მლნ.
EBT including unusual items
1,60 მლრდ.
1,40 მლრდ.
1,84 მლრდ.
1,77 მლრდ.
EBT excluding unusual items
1,68 მლრდ.
1,66 მლრდ.
2,16 მლრდ.
1,82 მლრდ.
Income tax expense
215,00 მლნ.
254,00 მლნ.
575,00 მლნ.
289,00 მლნ.
Effective tax rate
13,47%
18,10%
31,34%
16,35%
Other operating expenses
-29,00 მლნ.
-79,00 მლნ.
126,00 მლნ.
113,00 მლნ.
Net income
1,37 მლრდ.
1,14 მლრდ.
1,24 მლრდ.
1,47 მლრდ.
Net profit margin
15,33%
12,68%
12,68%
15,07%
Earnings per share
1,36
1,36
1,55
1,45
Interest and investment income
89,00 მლნ.
102,00 მლნ.
73,00 მლნ.
102,00 მლნ.
Interest expense
-181,00 მლნ.
-181,00 მლნ.
-176,00 მლნ.
-186,00 მლნ.
Net interest expenses
-92,00 მლნ.
-79,00 მლნ.
-103,00 მლნ.
-84,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,52 მლრდ.
2,52 მლრდ.
2,88 მლრდ.
2,62 მლრდ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები